Bio-Rad Laboratories ROA 2006-2018 | BIO

Current and historical return on assets (ROA) values for Bio-Rad Laboratories (BIO) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Bio-Rad Laboratories ROA for the three months ending September 30, 2018 was 2.67%.
Bio-Rad Laboratories ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2018-09-30 $1.28B $6.72B 21.65%
2018-06-30 $1.03B $6.39B 19.56%
2018-03-31 $0.77B $6.22B 16.30%
2017-12-31 $0.12B $4.27B 2.95%
2017-09-30 $0.02B $4.19B 0.40%
2017-06-30 $0.01B $4.14B 0.30%
2017-03-31 $0.03B $3.95B 0.64%
2016-12-31 $0.03B $3.85B 0.65%
2016-09-30 $0.09B $4.02B 2.45%
2016-06-30 $0.09B $3.88B 2.48%
2016-03-31 $0.10B $3.75B 2.81%
2015-12-31 $0.11B $3.71B 3.06%
2015-09-30 $0.10B $3.67B 2.94%
2015-06-30 $0.10B $3.53B 2.86%
2015-03-31 $0.10B $3.33B 2.99%
2014-12-31 $0.09B $3.34B 2.64%
2014-09-30 $0.08B $3.39B 2.37%
2014-06-30 $0.06B $3.47B 1.83%
2014-03-31 $0.07B $3.44B 1.91%
2013-12-31 $0.08B $3.39B 2.29%
2013-09-30 $0.09B $3.28B 2.66%
2013-06-30 $0.14B $3.48B 4.12%
2013-03-31 $0.15B $3.46B 4.61%
2012-12-31 $0.17B $3.44B 5.04%
2012-09-30 $0.18B $3.30B 5.71%
2012-06-30 $0.19B $3.17B 5.96%
2012-03-31 $0.18B $3.19B 5.76%
2011-12-31 $0.18B $3.10B 5.96%
2011-09-30 $0.19B $2.97B 6.24%
2011-06-30 $0.19B $3.04B 6.36%
2011-03-31 $0.18B $2.91B 6.58%
2010-12-31 $0.19B $3.06B 6.88%
2010-09-30 $0.16B $2.68B 6.06%
2010-06-30 $0.15B $2.53B 5.95%
2010-03-31 $0.15B $2.55B 6.06%
2009-12-31 $0.15B $2.54B 6.23%
2009-09-30 $0.10B $2.48B 4.49%
2009-06-30 $0.09B $2.34B 4.22%
2009-03-31 $0.09B $1.96B 4.59%
2008-12-31 $0.09B $2.04B 4.34%
2008-09-30 $0.11B $2.02B 5.36%
2008-06-30 $0.11B $2.10B 5.56%
2008-03-31 $0.09B $2.05B 4.98%
2007-12-31 $0.09B $1.97B 5.36%
2007-09-30 $0.10B $1.71B 5.97%
2007-06-30 $0.09B $1.66B 5.83%
2007-03-31 $0.10B $1.61B 6.37%
2006-12-31 $0.10B $1.60B 6.83%
2006-09-30 $0.10B $1.52B 6.76%
2006-06-30 $0.09B $1.49B 6.39%
2006-03-31 $0.08B $1.42B 5.51%
2005-12-31 $0.08B $1.43B 5.67%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $8.054B $2.160B
Bio-Rad Laboratories, Inc., together with its subsidiaries, engages in the manufacture and supply of products and systems for the life science research, healthcare, analytical chemistry, and other markets worldwide. The company's products are used to separate complex chemical and biological materials, and to identify, analyze, and purify their components. It operates in two segments, Life Science and Clinical Diagnostics. The Life Science segment offers electrophoresis, image analysis, molecular detection, chromatography, gene transfer, sample preparation, and amplification products and services. The Clinical Diagnostics segment provides control, autoimmune, diabetes, and blood virus testing products. Bio-Rad is renowned worldwide among hospitals, universities, major research institutions, as well as biotechnology and pharmaceutical companies for its commitment to quality and customer service. The company is headquartered in Hercules, California.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $124.342B 19.06
Abbott Laboratories (ABT) United States $122.048B 24.73
Stryker (SYK) United States $62.796B 23.67
Boston Scientific (BSX) United States $50.730B 25.64
Baxter (BAX) United States $33.541B 21.66
Zimmer Biomet Holdings (ZBH) United States $23.031B 14.94
Smith & Nephew SNATS (SNN) United Kingdom $16.007B 0.00
ResMed (RMD) United States $14.492B 27.64
Canopy Growth (CGC) Canada $8.934B 0.00
Perrigo (PRGO) Ireland $8.884B 13.48
Aurora Cannabis (ACB) Canada $6.462B 35.26
Hill-Rom Holdings (HRC) United States $6.201B 19.66
Haemonetics (HAE) United States $5.495B 48.33
Insulet (PODD) United States $4.770B 0.00
ICU Medical (ICUI) United States $4.529B 25.23
Hutchison China MediTech (HCM) China $4.274B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.987B 0.00
Agios Pharmaceuticals (AGIO) United States $3.869B 0.00
Neogen (NEOG) United States $3.219B 48.74
National Vision Holdings (EYE) United States $3.101B 61.33
NuVasive (NUVA) United States $2.972B 27.65
Aphria (APHA) $2.572B 0.00
Quidel (QDEL) United States $2.478B 32.30
NxStage Medical (NXTM) United States $1.924B 0.00
Phibro Animal Health (PAHC) United States $1.476B 20.89
AtriCure (ATRC) United States $1.174B 0.00
Cardiovascular Systems (CSII) United States $1.015B 1462.50
VAREX IMAGING (VREX) United States $0.992B 19.93
Meridian Bioscience (VIVO) United States $0.827B 26.35
PetIQ (PETQ) United States $0.803B 22.83
OraSure Technologies (OSUR) United States $0.793B 44.65
Surmodics (SRDX) United States $0.776B 118.55
Eagle Pharmaceuticals (EGRX) United States $0.755B 24.22
Cerus (CERS) United States $0.719B 0.00
MacroGenics (MGNX) United States $0.710B 0.00
Omeros (OMER) United States $0.623B 0.00
Lantheus Holdings (LNTH) United States $0.590B 18.27
Owens & Minor (OMI) United States $0.558B 6.31
Insys Therapeutics (INSY) United States $0.542B 0.00
LeMaitre Vascular (LMAT) United States $0.518B 25.45
NanoString Technologies (NSTG) United States $0.481B 0.00
TG Therapeutics (TGTX) United States $0.438B 0.00
Evolus (EOLS) United States $0.399B 0.00
Quanterix (QTRX) United States $0.359B 0.00
Utah Medical Products (UTMD) United States $0.327B 21.12
Cytosorbents (CTSO) United States $0.302B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.255B 0.00
Surface Oncology (SURF) United States $0.226B 0.00
Rockwell Medical (RMTI) United States $0.211B 0.00
BioLife Solutions (BLFS) United States $0.206B 278.75
Bovie Medical (BVX) United States $0.201B 0.00
Chimerix (CMRX) United States $0.161B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.148B 0.00
Fonar (FONR) United States $0.139B 6.96
Chembio Diagnostics (CEMI) United States $0.104B 0.00
Imprimis Pharmaceuticals (IMMY) United States $0.081B 0.00
United-Guardian (UG) United States $0.079B 16.63
Female Health (VERU) United States $0.079B 0.00
Trinity Biotech (TRIB) Ireland $0.077B 24.40
Oramed Pharmaceuticals (ORMP) Israel $0.070B 0.00
InfuSystems Holdings (INFU) United States $0.067B 0.00
CAS Medical Systems (CASM) United States $0.056B 0.00
Neurotrope (NTRP) United States $0.050B 0.00
ImmuCell (ICCC) United States $0.041B 0.00
Capricor Therapeutics (CAPR) United States $0.028B 0.00
Myomo (MYO) United States $0.025B 0.00
Valeritas Holdings (VLRX) United States $0.021B 0.00
Senestech (SNES) United States $0.019B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.019B 0.00
Cellectar Biosciences (CLRB) United States $0.009B 0.00
NeuroMetrix (NURO) United States $0.007B 0.00
Akers Biosciences Inc (AKER) United States $0.000B 0.00